Codiak BioSciences' GAAP loss for 9M 2021 was $53.819 million, down 27% from $73.708 million in the previous year. Revenue increased 12-fold to $15.238 million from $1.275 million a year earlier.
Codiak BioSciences' GAAP loss for 9M 2021 was $53.819 million, down 27% from $73.708 million in the previous year. Revenue increased 12-fold to $15.238 million from $1.275 million a year earlier. 
ir.codiakbio.com
English (US) 